Baliopharm (investor - Corporate Investor)

See something wrong or missing? Let us know

Offices:

Baliopharn is a Swiss biotech company.

Average round investment:400k USD

Average number per year:1.00

Distribution: 2016 (1) See the entire list

Portfolio companies: portfolioItem.CountryName

3Z Pharmaceuticals See the entire list

Mostly invests in: Iceland

Iceland (1) Health services (1)

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.